About this file

This document contains questions and responses regarding federal solicitation number 75D301-23-Q-77082 for a cross-sectional, multistate, commercial laboratory assessment of viral hepatitis C prevalence. The solicitation, issued by the Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services, will utilize milestone payments according to the schedule in the solicitation, with other billing approaches not being accepted. While the sampling plan is not required to be submitted with a quote, details regarding a table displaying specimen size options with corresponding confidence intervals to potentially select from for an initial estimate to meet the requirements will be addressed during contract execution.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

75D301-23-Q-77082 Questions and Responses

1. Milestone Payments Schedule: Could you please explain further the billing by percentage milestones? Would CDC be open to other billing approaches?

Response: Payments will be made according to the schedule in the solicitaiton. Other approaches will not be accepted.

2. Regarding proposing sample size and selection approach, initial estimates to meet the requirements included in the notice (assuming 1% prevalence with +/- 0.1% Confidence) suggest a very large sample size. Would the CDC accept a table in the proposal displaying specimen size options with corresponding confidence intervals to select from?

Response: Please note that the sampling plan is not required to be submitted with a quote and that details regarding sampling will be addressed during contract execution.

File details come from the government source that posted it. Updated .